Your browser doesn't support javascript.
loading
Enhanced gefitinib-induced repression of the epidermal growth factor receptor pathway by ataxia telangiectasia-mutated kinase inhibition in non-small-cell lung cancer cells.
Misumi, Keizo; Sun, Jiying; Kinomura, Aiko; Miyata, Yoshihiro; Okada, Morihito; Tashiro, Satoshi.
Affiliation
  • Misumi K; Department of Cellular Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Sun J; Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Kinomura A; Department of Cellular Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Miyata Y; Department of Cellular Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Okada M; Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Tashiro S; Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Cancer Sci ; 107(4): 444-51, 2016 Apr.
Article in En | MEDLINE | ID: mdl-26825989

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Drug Resistance, Neoplasm / Ataxia Telangiectasia Mutated Proteins / ErbB Receptors Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cancer Sci Year: 2016 Type: Article Affiliation country: Japan

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Drug Resistance, Neoplasm / Ataxia Telangiectasia Mutated Proteins / ErbB Receptors Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cancer Sci Year: 2016 Type: Article Affiliation country: Japan